Pennsylvania Nurse Practitioner Prescriptive authority

Authority and qualifications for prescribing, dispensing and ordering drugs. (b) To obtain prescriptive authority approval, a CRNP shall: (1) Successfully complete at least 45 hours of course work specific to advanced pharmacology in accordance with the following:

(ii) The course work shall be at an advanced level above a pharmacology course required by a professional nursing (RN) education program. (iii) The course work shall have been completed within 5 years immediately preceding the date the applicant applies for initial prescriptive authority approval.

As a condition for obtaining Certified Registered Nurse Practitioner certification applicants must hold either a current, unrestricted Pennsylvania single state or multistate registered nurse license or a multistate registered nurse license issued by another Compact state

Authority and qualifications for prescribing, dispensing and ordering drugs. (b) To obtain prescriptive authority approval, a CRNP shall: (1) Successfully complete at least 45 hours of course work specific to advanced pharmacology in accordance with the following:

(ii) The course work shall be at an advanced level above a pharmacology course required by a professional nursing (RN) education program. (iii) The course work shall have been completed within 5 years immediately preceding the date the applicant applies for initial prescriptive authority approval.

As a condition for obtaining Certified Registered Nurse Practitioner certification applicants must hold either a current, unrestricted Pennsylvania single state or multistate registered nurse license or a multistate registered nurse license issued by another Compact state

Certified Registered Nurse Practitioners; Qualifications.--(a) The board may certify a licensed registered nurse as a certified registered nurse practitioner in a particular clinical specialty area if the nurse satisfies the requirements established by this act and regulations promulgated by the board.

*National certification*—Certification by a Board-recognized National certification organization which required passing a nurse practitioner National certifying examination in a specialty.

Authority and qualifications for prescribing, dispensing and ordering drugs. (b) To obtain prescriptive authority approval, a CRNP shall: (1) Successfully complete at least 45 hours of course work specific to advanced pharmacology in accordance with the following:

(ii) The course work shall be at an advanced level above a pharmacology course required by a professional nursing (RN) education program. (iii) The course work shall have been completed within 5 years immediately preceding the date the applicant applies for initial prescriptive authority approval.

CRNP Practice. (a) A CRNP may collaborate only with physicians who hold a current license to practice in this Commonwealth. (b) When acting in collaboration with a physician as set forth in a collaborative agreement and within the CRNP’s specialty, a CRNP may: (1) Perform comprehensive assessments of patients and establish medical diagnoses

*Prescriptive authority collaborative agreement*—The written and signed agreement between a CRNP with prescriptive authority and a collaborating physician in which they agree to the details of their collaboration

CRNP Practice. (a) A CRNP may collaborate only with physicians who hold a current license to practice in this Commonwealth. (b) When acting in collaboration with a physician as set forth in a collaborative agreement and within the CRNP’s specialty, a CRNP may: (1) Perform comprehensive assessments of patients and establish medical diagnoses

Prescribing and dispensing parameters. (b) A CRNP with current prescriptive authority approval from the Board may prescribe, dispense and administer drugs and therapeutic or corrective measures consistent with the prescriptive authority collaborative agreement and relevant to the CRNP’s specialty from the following categories: (1) Antihistamines.

*Prescriptive authority collaborative agreement*—The written and signed agreement between a CRNP with prescriptive authority and a collaborating physician in which they agree to the details of their collaboration

CRNP Practice. (a) A CRNP may collaborate only with physicians who hold a current license to practice in this Commonwealth. (b) When acting in collaboration with a physician as set forth in a collaborative agreement and within the CRNP’s specialty, a CRNP may: (1) Perform comprehensive assessments of patients and establish medical diagnoses

(2) A CRNP may prescribe a Schedule III or IV controlled substance for up to a 90 day supply as identified in the collaborative agreement. (e) A CRNP may not delegate prescriptive authority.

nurse practitioners, by or pursuant to law or regulation shall, after the effective date of this subsection, be exercised solely by the State Board of Nursing.

DEA regulations require a separate registration for each principal place of business or professional practice at one general physical location where controlled substances are manufactured, distributed, imported, exported, or dispensed by a person.

Thus, a DEA registration based on a State license cannot authorize controlled substance dispensing outside the State.

Answer: Your registered address must be the physical location of your principal place of business or professional practice where controlled substances are manufactured, distributed, imported, exported, or dispensed.

Since DEA's authority to register practitioners to dispense (including to prescribe) controlled substances is contingent, in part, upon the applicant's authorization in the state in which he or she practices, his or her controlled substance privileges and limits are determined by that specific state.

DEA relies on State licensing boards to determine whether a practitioner is qualified to dispense, prescribe, or administer controlled substances and to determine which schedules he/she may dispense, prescribe, or administer.

Thus, a DEA registration based on a State license cannot authorize controlled substance dispensing outside the State.

Answer: Your registered address must be the physical location of your principal place of business or professional practice where controlled substances are manufactured, distributed, imported, exported, or dispensed.

Answer: Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form—regardless of whether a registrant is completing their initial registration application or renewing their registration—affirming that they have completed the new training requirement.

Answer: The deadline for satisfying this new training requirement is the date of a practitioner's next scheduled DEA registration submission—regardless of whether it is an initial registration or a renewal registration—on or after June 27, 2023.

This one-time training requirement affirmation will not be a part of future registration renewals.

It should be noted that this is a one-time attestation and trainings can occur in classroom settings, seminars at professional society meetings, or virtual offerings.

Since DEA's authority to register practitioners to dispense (including to prescribe) controlled substances is contingent, in part, upon the applicant's authorization in the state in which he or she practices, his or her controlled substance privileges and limits are determined by that specific state.

DEA relies on State licensing boards to determine whether a practitioner is qualified to dispense, prescribe, or administer controlled substances and to determine which schedules he/she may dispense, prescribe, or administer.

Examples of mid-level practitioners include, but are not limited to, health care providers such as nurse practitioners, nurse midwives, nurse anesthetists, clinical nurse specialists and physician assistants who are authorized to dispense controlled substances by the State in which they practice.

DEA regulations require a separate registration for each principal place of business or professional practice at one general physical location where controlled substances are manufactured, distributed, imported, exported, or dispensed by a person.

A mid-level practitioner means an individual practitioner, other than a physician, dentist, veterinarian, or podiatrist, who is licensed, registered, or otherwise permitted by the United States or the jurisdiction in which he/she practices, to dispense a controlled substance in the course of professional practice.

Examples of mid-level practitioners include, but are not limited to, health care providers such as nurse practitioners, nurse midwives, nurse anesthetists, clinical nurse specialists and physician assistants who are authorized to dispense controlled substances by the State in which they practice.

Answer: Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form—regardless of whether a registrant is completing their initial registration application or renewing their registration—affirming that they have completed the new training requirement.

Answer: The deadline for satisfying this new training requirement is the date of a practitioner's next scheduled DEA registration submission—regardless of whether it is an initial registration or a renewal registration—on or after June 27, 2023.

This one-time training requirement affirmation will not be a part of future registration renewals.

It should be noted that this is a one-time attestation and trainings can occur in classroom settings, seminars at professional society meetings, or virtual offerings.

Those applicants, other than a physician or a veterinarian, legally authorized by the State to dispense controlled medications under schedules II-V, may meet the training requirement when they have graduated in good standing from an accredited physician assistant school or accredited school of advanced practice nursing in the United States during the past 5 years, and successfully completed a comprehensive physician assistant or advanced practice nursing curriculum that

5 years, and successfully completed a comprehensive physician assistant or advanced practice nursing curriculum that included at least 8 hours of training on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all medications approved by the FDA for the treatment of substance use disorder.

For those applicants who are non-physicians and legally authorized by the State to dispense controlled medications under schedules II-V, at least 8 hours of training must include training with respect to the treatment and management of patients with opioid or other substance use disorders delivered by an entity listed in the CAA.

It is recommended that each practitioner keep a record of training certificates or other materials documenting completion.

However, these documents will not need to be submitted to DEA for review at the time of initial application or renewal of registration.

Those applicants, other than a physician or a veterinarian, legally authorized by the State to dispense controlled medications under schedules II-V, may meet the training requirement when they have graduated in good standing from an accredited physician assistant school or accredited school of advanced practice nursing in the United States during the past 5 years, and successfully completed a comprehensive physician assistant or advanced practice nursing curriculum that

5 years, and successfully completed a comprehensive physician assistant or advanced practice nursing curriculum that included at least 8 hours of training on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all medications approved by the FDA for the treatment of substance use disorder.

For those applicants who are non-physicians and legally authorized by the State to dispense controlled medications under schedules II-V, at least 8 hours of training must include training with respect to the treatment and management of patients with opioid or other substance use disorders delivered by an entity listed in the CAA.

DEA has modified the DEA Form 224 and DEA Form-224a applications for registration/renewal, in order for practitioners to attest to the training standards at their first applicable registration.

The term "first applicable registration" means the first registration or renewal of registration by a qualified practitioner on or after June 27, 2023, under 21 U.S.C. 823(l)(4)(A).

The updated forms will be available from June 27, 2023, and include a section where a practitioner will attest to meeting the required training according to one of the standards identified above.

It is recommended that each practitioner keep a record of training certificates or other materials documenting completion.

However, these documents will not need to be submitted to DEA for review at the time of initial application or renewal of registration.

Answer: All DEA-registered practitioners, with the exception of practitioners that are solely veterinarians.

Answer: Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form—regardless of whether a registrant is completing their initial registration application or renewing their registration—affirming that they have completed the new training requirement.

Answer: The deadline for satisfying this new training requirement is the date of a practitioner's next scheduled DEA registration submission—regardless of whether it is an initial registration or a renewal registration—on or after June 27, 2023.

This one-time training requirement affirmation will not be a part of future registration renewals.

It should be noted that this is a one-time attestation and trainings can occur in classroom settings, seminars at professional society meetings, or virtual offerings.

Fees. (a) The following application fees are charged by the Board for services to licensees and applicants: CRNP Certification—Board-approved nursing education program graduates $100 CRNP Certification—graduates of out-of-State nursing education programs $140 Verification of certification $45 Verification of certification with history $50 Application for prescriptive authority $95

Fees. Each additional application for prescriptive authority $45 Restoration of CRNP certification after suspension or revocation $60 Restoration of CRNP prescriptive authority after suspension or revocation $60 (b) The following renewal fees are charged by the Board to support its operations: Biennial renewal of CRNP certification $81 Biennial renewal of prescriptive authority approval $41

Each additional application for prescriptive authority $45 Restoration of CRNP certification after suspension or revocation $60 Restoration of CRNP prescriptive authority after suspension or revocation $60 (b) The following renewal fees are charged by the Board to support its operations: Biennial renewal of CRNP certification $81 Biennial renewal of prescriptive authority approval $41

(2) Submit an application for prescriptive authority approval to the Board

Application for certification. (a) Applicants for certification shall pay a fee set forth in § 21.253 (relating to fees), and submit an application form provided by the Board to the Board for its review and approval.

The Board does not believe it is necessary to repeat these statutory provisions because CRNPs are required to submit their prescriptive authority collaborative agreements on a form provided by the Board and the form includes the three provisions found in section 8.3(a)(2)(i)—(iii) of the act, as well as additional information that must be submitted to the Board

Application for certification. (a) Applicants for certification shall pay a fee set forth in § 21.253 (relating to fees), and submit an application form provided by the Board to the Board for its review and approval.

Authority and qualifications for prescribing, dispensing and ordering drugs. (b) To obtain prescriptive authority approval, a CRNP shall: (1) Successfully complete at least 45 hours of course work specific to advanced pharmacology in accordance with the following:

(2) Submit an application for prescriptive authority approval to the Board

The Board does not believe it is necessary to repeat these statutory provisions because CRNPs are required to submit their prescriptive authority collaborative agreements on a form provided by the Board and the form includes the three provisions found in section 8.3(a)(2)(i)—(iii) of the act, as well as additional information that must be submitted to the Board

nurse practitioners, by or pursuant to law or regulation shall, after the effective date of this subsection, be exercised solely by the State Board of Nursing.

DEA relies on State licensing boards to determine whether a practitioner is qualified to dispense, prescribe, or administer controlled substances and to determine which schedules he/she may dispense, prescribe, or administer.

The Pennsylvania Code website reflects the *Pennsylvania Code* changes effective through 56 Pa.B.

200 (January 3, 2026).

nurse practitioners, by or pursuant to law or regulation shall, after the effective date of this subsection, be exercised solely by the State Board of Nursing.

DEA relies on State licensing boards to determine whether a practitioner is qualified to dispense, prescribe, or administer controlled substances and to determine which schedules he/she may dispense, prescribe, or administer.

nurse practitioners, by or pursuant to law or regulation shall, after the effective date of this subsection, be exercised solely by the State Board of Nursing.

Certified Registered Nurse Practitioners; Qualifications.--(a) The board may certify a licensed registered nurse as a certified registered nurse practitioner in a particular clinical specialty area if the nurse satisfies the requirements established by this act and regulations promulgated by the board.

Since DEA's authority to register practitioners to dispense (including to prescribe) controlled substances is contingent, in part, upon the applicant's authorization in the state in which he or she practices, his or her controlled substance privileges and limits are determined by that specific state.

Answer: As a condition of registration, the new training requirement in section 1263(a) of the CAA went into effect on June 27, 2023, and applies to all qualified practitioners when they apply for a new registration or a renewal of registration on or after that date.